FOR IMMEDIATE DISTRIBUTION
NEW YORK, April 10, 2007 -- Jefferies & Company, Inc., the principal operating subsidiary of Jefferies Group, Inc. (NYSE: JEF), today announced the hiring of Peter J. Bye as a Managing Director and Senior Equity Research Analyst covering medical devices & diagnostics companies.
Mr. Bye has nearly a decade of experience in healthcare research and joins Senior Equity Research analyst, Mark J. Richter, to further expand Jefferies’ coverage of these rapidly growing industries. Jefferies’ global coverage of the healthcare sector includes biotechnology, facility-based services, healthcare IT services, specialty services and supplies, managed care, pharmaceutical services, and specialty pharmaceuticals.
Jefferies’ broader focus on the global healthcare sector also includes six dedicated securities traders and nearly 35 investment banking professionals focused on healthcare services and life sciences.
“Peter Bye’s experience in sell-side research and specialized healthcare companies is complementary to our established coverage of growing companies in the healthcare sector,” commented Steven R. Black, Director of Equity Research at Jefferies. “We remain deeply committed to bringing new and innovative investment ideas to our clients.”
“Medical devices & diagnostics companies garner significant investor interest and are an increasingly important area of healthcare in terms of ongoing advancements and their overall impact on the healthcare landscape,” commented Mr. Bye. “I am delighted to join Jefferies’ award-winning research effort and to apply my insight and analytical skills for the benefit of the Firm’s clients.”
Jefferies’ broad equity research effort has received key industry accolades, ranking second in The Wall Street Journal “Best on the Street” 2005 Analysts Survey with a total of eight awards. The Firm was also among the Top 10 most award-winning brokers as ranked by StarMine in 2004, with eight analyst honors. In total, Jefferies and its affiliates now have more than 140 equity, high yield and convertible research professionals in the US, Europe and Asia covering over 1,300 companies in the areas of aerospace and defense, business, consumer, financial and IT services, energy, gaming, healthcare, industrial, media and entertainment, shipping, transport and logistics, technology and telecommunications.
Mr. Bye was most recently a senior research analyst at Wachovia Securities, where he covered small- and mid-cap medical technology companies. Previously, he had a similar role at Citigroup/Smith Barney. Mr. Bye also covered ophthalmology, surgery and respiratory/home health as an equity research analyst at SG Cowen Securities. While at Warburg Dillon Read, he and his team covered medical technology companies. He has an A.B. from Harvard University.
Mr. Bye will be based in Jefferies' New York headquarters office and reports to Mr. Black.
About Jefferies
Jefferies, a global investment bank and institutional securities firm, has served growing and mid-sized companies and their investors for 45 years. Headquartered in New York, with more than 25 offices around the world, Jefferies provides clients with capital markets and financial advisory services, institutional brokerage, securities research and asset management. The firm is a leading provider of trade execution in equity, high yield, convertible and international securities for institutional investors and high net worth individuals. Jefferies & Company, Inc. is the principal operating subsidiary of Jefferies Group, Inc. (NYSE: JEF; www.jefferies.com).
For further information, please contact:
Tom Tarrant, Jefferies & Company, Inc., 203 708 5989, ttarrant@jefferies.com
Todd Miller, Cubitt Jacobs & Prosek, 203 378 1152, x149, Todd@cjpcom.com
